Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,578 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06632574RecruitingPhase 1
Paclitaxel liposomes via artery for advanced solid tumors
This trial tests a new form of paclitaxel (a chemotherapy drug) wrapped in tiny fat bubbles called liposomes. It is given directly into an artery that feeds the tumor, which may deliver the drug more effectively to the cancer. The study is for people with advanced solid tumors that can be treated this way, such as stomach, liver, pancreatic, or lung cancers.
NanjingAges 18 years+ - NCT06611839RecruitingPhase 1/Phase 2
Combination therapy for IDH1-mutated AML
This trial tests a combination of three drugs (venetoclax, ivosidenib, and azacitidine) for people newly diagnosed with a specific type of AML that has an IDH1 mutation. The goal is to see if this mix works better than standard treatments.
Tianjin, Tianjin MunicipalityAges 14 years+ - NCT06671743RecruitingPhase 3
Medication before root canal to reduce pain
This study tests whether taking a medication before a root canal can reduce pain afterward. It is for people who need a root canal on a lower back tooth that has a painful, inflamed nerve but no infection at the root tip.
AjmanAges 20–50 - NCT06676267Recruiting
Laparoscopic surgery for gynecological and remote procedures
This trial tests a laparoscopic surgical system for gynecological and remote surgeries. It may help patients who need minimally invasive surgery and can follow the study plan.
Nantong, JiangsuAges 18–80 - NCT06672705RecruitingPhase 1
Epcoritamab for post-transplant lymphoma that didn't respond to treatment
This trial tests a new drug called epcoritamab for people whose PTLD (a type of lymphoma that can happen after an organ transplant) has come back or hasn't been helped by standard treatments. The goal is to see if epcoritamab can shrink or control the cancer.
St Louis, MissouriAges 18 years+ - NCT06616129Recruiting
Geriatric risk assessment for older heart surgery patients
This study tests whether a special geriatric risk assessment and shared decision-making conversation helps older patients (70+) and their doctors choose the best treatment for heart surgery. It aims to improve quality of life by tailoring decisions to each person's health risks.
Groningen, Provincie GroningenAges 70 years+ - NCT06652347Recruiting
Older adults' views on geriatric tests for cancer treatment planning
This study asks adults aged 65 and older about their views on geriatric and functional assessments to help plan cancer treatment. It tests whether these assessments are acceptable and useful to patients.
Philadelphia, PennsylvaniaAges 65 years+ - NCT06669611RecruitingPhase 3
Comparing two drug combos for advanced nasopharyngeal cancer
This trial tests whether a new drug combination (Nab-Paclitaxel with Camrelizumab) works better than the standard GP chemotherapy plus Camrelizumab for people whose nasopharyngeal cancer has come back or spread. The goal is to find a more effective treatment option.
Guangzhou, GuangdongAges 18 years+ - NCT06650267RecruitingPhase 2
Substance use and family violence treatment for fathers
This study tests a treatment program for fathers who have both a substance use disorder and a history of family violence within the last 18 months. The goal is to see if the program helps reduce substance misuse and improve family relationships.
New Haven, ConnecticutAges 18 years+ - NCT06636357RecruitingPhase 2
Laughing gas for acute suicidal thoughts
This study tests whether breathing a mixture of nitrous oxide (laughing gas) and oxygen can quickly reduce strong suicidal thoughts. It's for people experiencing a mental health crisis who may need fast relief.
ZurichAges 18–65 - NCT06654804RecruitingPhase 4
Contrast ultrasound for acute spinal cord injury
This trial tests if a contrast dye used with ultrasound can help treat recent spinal cord injuries. You may qualify if you had a spinal cord injury less than 24 hours ago and need surgery to fix the spine.
Seattle, WashingtonAges 18 years+ - NCT06580899Enrolling by invitationPhase 4
Knee pain pump study for single knee replacement surgery
This study tests whether a small pain pump placed in your knee joint during surgery can help control pain after a single knee replacement. It is for people who are having outpatient knee replacement surgery and have not been taking strong pain medicines recently.
Charlotte, North CarolinaAges 18 years+ - NCT06563245RecruitingPhase 2/Phase 3
Brentuximab vedotin for Hodgkin lymphoma in children and young adults
This trial tests the drug brentuximab vedotin for children and young adults (ages 2 to under 35) who have just been diagnosed with classical Hodgkin lymphoma. The treatment is guided by PET/CT scans to see how well it works.
ShanghaiAges 2–35 - NCT06561139Recruiting
Mindfulness for problem gambling
This trial tests if adding mindfulness training to your current treatment for problem gambling can help you more. You can join if you are already receiving treatment for problem gambling in Sweden.
MalmöAges 18 years+ - NCT06566274Recruiting
Thumbtack needle for nausea and vomiting in pregnancy
This trial tests a thumbtack needle (a tiny acupuncture technique) to treat nausea and vomiting in early pregnancy. It may help if you have moderate to severe morning sickness and are between 6 to 12 weeks pregnant.
Jingzhou, HubeiAges 20–45 - NCT06562777Recruiting
How symptoms differ between men and women during immunotherapy
This study looks at how symptoms during immunotherapy (a cancer treatment that boosts your immune system) may differ between men and women. Researchers will follow people with cancer who are starting immunotherapy to see if men and women report different side effects.
Portland, OregonAges 18 years+ - NCT06761417RecruitingPhase 2
Liposomal mitoxantrone for children and young adults with relapsed solid tumors
This trial tests a new form of chemotherapy (liposomal mitoxantrone) for children, adolescents, and young adults whose solid tumors have come back or not responded to treatment. The goal is to see if this combination regimen can help shrink tumors.
BeijingAges 6–24 - NCT06535269Recruiting
Pain after hemorrhoid surgery: standard vs bipolar sealer
This study compares two ways of removing hemorrhoids during surgery: one uses a standard electric tool, the other uses a special device (Caiman®) that seals blood vessels. It aims to see which method causes less pain after the operation.
Sabadell, BarcelonaAges 18–65 - NCT06568679Recruiting
Improving detection and treatment of early-onset colorectal cancer
This study aims to find better ways to detect and treat colorectal cancer in younger adults (ages 18–49). It includes people with both early-stage and advanced cancer.
Amsterdam, North HollandAges 18–49 - NCT06548919Recruiting
Treatment patterns for ESR1-mutated advanced breast cancer
This study looks at how Chinese patients with a specific gene change (ESR1 mutation) in ER-positive, HER2-negative advanced breast cancer are currently being treated. It will help doctors understand what treatments work best for people whose cancer has stopped responding to hormone therapy.
Suzhou, JiangsuAges 18 years+ - NCT06582342Recruiting
Does a 3D model predict treatment response better than CT for pancreatic cancer?
This study tests whether a special 3D scan can better tell if treatment has shrunk the tumor in people with pancreatic cancer. It may help your doctors decide if surgery is a good option.
AlicanteAges 18 years+ - NCT06583720RecruitingPhase 1
Light therapy and probiotics for bad breath
This trial tests a new approach for treating bad breath (halitosis) using a special light therapy combined with probiotics (good bacteria). It aims to see if this combination works better than standard treatments.
São Paulo, São PauloAges 18–60 - NCT06404931RecruitingPhase 2
New material for vaginal prolapse repair
This trial tests a new material made from donated human tissue to repair pelvic organ prolapse. It may help women with certain types of prolapse who have not had prior pelvic surgery.
TerrassaAges 18–100 - NCT06454396Recruiting
Treating blocked dialysis fistulas from inside the blood vessel
This trial tests a new way to reopen blocked or narrowed fistulas (the blood vessels used for dialysis) in people on hemodialysis. The goal is to see how well it works and if it saves money compared to other treatments.
Shanghai, Shanghai MunicipalityAges 18–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,578 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.